A Phase 1 Pharmacokinetic-pharmacodynamic Study Of Avelumab (msb0010718c) In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma
Phase of Trial: Phase I
Latest Information Update: 17 Oct 2017
At a glance
- Drugs Avelumab (Primary)
- Indications Hodgkin's disease
- Focus Pharmacokinetics
- Acronyms JAVELIN HODGKINS
- Sponsors Pfizer
- 11 Oct 2017 Planned End Date changed from 1 Sep 2017 to 20 Aug 2020.
- 11 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 20 Aug 2020.
- 10 Jun 2017 Biomarkers information updated